What drives IDIA.SW stock pre-market volume today?

Pre-market volume is driven by pipeline milestones and renewed interest from momentum traders. High relative volume (**2.26x**) reflects speculation around partner deals and upcoming earnings on 2026-04-28, plus technical momentum off the 50-day average.

How does Idorsia's valuation compare to the healthcare sector?

IDIA.SW stock shows a negative PE (**-6.64**) and price-to-sales **3.72**, versus the Healthcare sector average PE **35.21**. The gap reflects current losses and development-stage risk; valuation is sensitive to trial outcomes and partner revenue.

What are Meyka AI’s short-term targets for IDIA.SW stock?

Meyka AI's forecast model projects monthly **CHF 4.05**, quarterly **CHF 5.39**, and yearly **CHF 5.43**. These are model projections, not guarantees, and should be combined with event risk management and position sizing.

What risk controls should active traders use on IDIA.SW stock?

Active traders should size positions to event risk, use a stop near **CHF 3.70**, and consider profit-taking around resistance levels (near **CHF 4.85**). Monitor liquidity and news flow ahead of earnings and trial readouts.

CH Stocks

CHF 4.12 IDIA.SW Idorsia (SIX) pre-market: 3.16M shares active, catalysts ahead

ByHuzaifa Zahoor March 3, 2026March 3, 2026

The IDIA.SW stock opened pre-market on 03 Mar 2026 at CHF 4.12, trading 3,164,598 shares so far and up 5.24% versus the prior close. This level sits above the 50-day average of CHF 3.86 and shows elevated interest on the SIX Switzerland session. Traders are watching pipeline catalysts, near-term earnings and today’s heavy volume for signals on direction.